ARDX
Ardelyx Inc
Price:  
6.04 
USD
Volume:  
3,008,123.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-164.9%
Upside

As of 2024-10-12, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -27.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,480.36 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -54.24 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.4x - 16.7x 13.9x
Forward P/E multiples 15.5x - 20.0x 18.0x
Fair Price (3.83) - (4.10) (3.92)
Upside -163.4% - -167.9% -164.9%
6.04 USD
Stock Price
(3.92) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-11 -27.30
2024-10-10 -27.30
2024-10-09 -26.56
2024-10-08 -26.95
2024-10-07 -27.69
2024-10-04 -30.68
2024-10-03 -29.99
2024-10-02 -31.16
2024-10-01 -30.81
2024-09-30 -30.99
2024-09-27 -29.94
2024-09-26 -28.68
2024-09-25 -27.43
2024-09-24 -26.82
2024-09-23 -26.77
2024-09-20 -27.69
2024-09-19 -27.08
2024-09-18 -26.69
2024-09-17 -27.77
2024-09-16 -28.08
2024-09-13 -28.47
2024-09-12 -28.08
2024-09-11 -26.95
2024-09-10 -25.78
2024-09-09 -25.78
2024-09-06 -25.39
2024-09-05 -26.12
2024-09-04 -25.69
2024-09-03 -25.52
2024-08-30 -27.90
2024-08-29 -27.69
2024-08-28 -27.77
2024-08-27 -28.08
2024-08-26 -28.47
2024-08-23 -28.64
2024-08-22 -27.34
2024-08-21 -28.73
2024-08-20 -27.64
2024-08-19 -27.08
2024-08-16 -26.47
2024-08-15 -26.60
2024-08-14 -25.73
2024-08-13 -26.25
2024-08-12 -26.34
2024-08-09 -25.82
2024-08-08 -26.56
2024-08-07 -25.17
2024-08-06 -27.47
2024-08-05 -26.38
2024-08-02 -27.34